GRAY logo

Graybug Vision (GRAY) Stock

Profile

Full Name:

Graybug Vision, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

04 September 2020

Indexes:

Not included

Website:

http://www.graybug.vision

Description:

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$23.24(+1.78% YoY)

PE Ratio

-

Annual ROE

-98.98%

Annual Debt To Equity

0.01

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 12, 2021

Recent annual earnings:

Mar 04, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 20, 2023

Analyst ratings

Recent major analysts updates

24 Mar '23 Oppenheimer
Outperform
19 May '22 Piper Sandler
Neutral
17 Mar '22 Cantor Fitzgerald
Overweight
13 May '21 SVB Leerink
Market Perform
13 May '21 Needham
Hold
10 Mar '21 Wedbush
Neutral
09 Mar '21 SVB Leerink
Outperform
09 Mar '21 Piper Sandler
Neutral
22 Dec '20 Cantor Fitzgerald
Overweight
25 Nov '20 Wedbush
Outperform

Screeners with GRAY included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$35.00
GRAY price is currently at an all-time high

Price Analysts Target

$49.00
GRAY price is currently equal to the consensus analysts' forecast

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Net Income 3-Year Change

+3.87%
GRAY annual net profit is up +3.87% over the past 3 years

Annual EPS 3-Year Change

+45.55%
GRAY annual earnings per share is up +45.55% over the past 3 years

Annual EPS Estimate

-$1.66
GRAY annual earnings per share is currently +1300.00% higher than the consensus analysts' forecast

Annual Operating Profit

-$33.22 M
GRAY annual operaing income is -$33.22 million

Annual Operating Profit 3-Year Change

+11.43%
GRAY annual operaing income is up +11.43% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

-98.98%
GRAY annual return on equity is -98.98%

Annual ROA

-89.75%
GRAY annual return on assets is -89.75%

Annual EBIT

-$33.22 M
GRAY annual earnings before interest & taxes is -$33.22 million

Annual EBITDA

-$32.88 M
GRAY annual earnings before interest, taxes, depreciation & amortization is -$32.88 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

10.72
GRAY annual current ratio is 10.72

Annual Total Assets

$39.67 M
GRAY annual total assets is $39.67 million

Annual Current Assets

$39.67 M
GRAY annual total current assets is $39.67 million

Annual Total Liabilities

$3.70 M
GRAY annual total liabilities is $3.70 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

+26.71%
GRAY annual cash flow from operations is up +26.71% over the past 3 years

Annual CFI 3-Year Change

+230.74%
GRAY annual cash flow from investing activities is up +230.74% over the past 3 years

Annual CFF 3-Year Change

-100.25%
GRAY annual cash flow from financing activities is down -100.25% over the past 3 years

Annual FCF

-$25.13 M
GRAY annual free cash flow is -$25.13 million

Annual FCF 3-Year Change

+21.02%
GRAY annual free cash flow is up +21.02% over the past 3 years

Institutional Ownership

Similar stocks

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL
GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL
GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL
GRAY
globenewswire.com22 January 2025

ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended December 31, 2024 on Thursday, February 27, 2025.

GENAI ANNOUNCES CHANGE OF MANAGEMENT AND APPOINTMENT OF PATRICK GRAY AS CEO
GENAI ANNOUNCES CHANGE OF MANAGEMENT AND APPOINTMENT OF PATRICK GRAY AS CEO
GENAI ANNOUNCES CHANGE OF MANAGEMENT AND APPOINTMENT OF PATRICK GRAY AS CEO
GRAY
prnewswire.com06 January 2025

VANCOUVER, BC , Jan. 6, 2025 /PRNewswire/ - Generative AI Solutions Corp. ("GenAI" or the "Company") (CSE: AICO) (OTCQB: AICOF) announces that Mr. Patrick Gray has been appointed Chief Executive Officer and a director of the Company, effective January 6, 2025.

GRAY MEDIA AND THE NATIONAL COLLEGIATE HOCKEY CONFERENCE TEAM UP TO BRING ELITE COLLEGE HOCKEY FREE OVER-THE-AIR TO VIEWERS ACROSS THE COUNTRY
GRAY MEDIA AND THE NATIONAL COLLEGIATE HOCKEY CONFERENCE TEAM UP TO BRING ELITE COLLEGE HOCKEY FREE OVER-THE-AIR TO VIEWERS ACROSS THE COUNTRY
GRAY MEDIA AND THE NATIONAL COLLEGIATE HOCKEY CONFERENCE TEAM UP TO BRING ELITE COLLEGE HOCKEY FREE OVER-THE-AIR TO VIEWERS ACROSS THE COUNTRY
GRAY
globenewswire.com06 December 2024

ATLANTA, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Gray Media (NYSE: GTN) and the National Collegiate Hockey Conference (NCHC) today announced that select NCHC college hockey games will appear free, over-the-air on Gray's market-leading television stations and over-the-air broadcast sports networks across the country. The first game, pitting No. 2-ranked and defending national champion Denver and No. 8-ranked Colorado College, will air in more than 20 Gray markets, including in St. Louis on Matrix Midwest Sports, throughout Louisiana on the Gulf Coast Sports & Entertainment Network, and across South Carolina on the Palmetto Sports & Entertainment Network on Friday, December 13, 2024 at 7 p.m. Mountain Time.

GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY
globenewswire.com08 November 2024

ATLANTA, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray”) (NYSE: GTN) announced today that its Board of Directors has authorized a quarterly cash dividend of $0.08 per share of its common stock and Class A common stock. The dividend is payable on December 31, 2024, to shareholders of record at the close of business on December 13, 2024.

GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
GRAY
globenewswire.com08 August 2024

ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray”) (NYSE: GTN) announced today that its Board of Directors has authorized a quarterly cash dividend of $0.08 per share of its common stock and Class A common stock. The dividend is payable on September 30, 2024, to shareholders of record at the close of business on September 13, 2024.

FAQ

  • What is the primary business of Graybug Vision?
  • What is the ticker symbol for Graybug Vision?
  • Does Graybug Vision pay dividends?
  • What sector is Graybug Vision in?
  • What industry is Graybug Vision in?
  • What country is Graybug Vision based in?
  • When did Graybug Vision go public?
  • Is Graybug Vision in the S&P 500?
  • Is Graybug Vision in the NASDAQ 100?
  • Is Graybug Vision in the Dow Jones?
  • When was Graybug Vision's last earnings report?
  • When does Graybug Vision report earnings?
  • Should I buy Graybug Vision stock now?

What is the primary business of Graybug Vision?

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

What is the ticker symbol for Graybug Vision?

The ticker symbol for Graybug Vision is NASDAQ:GRAY

Does Graybug Vision pay dividends?

No, Graybug Vision does not pay dividends

What sector is Graybug Vision in?

Graybug Vision is in the Healthcare sector

What industry is Graybug Vision in?

Graybug Vision is in the Biotechnology industry

What country is Graybug Vision based in?

Graybug Vision is headquartered in United States

When did Graybug Vision go public?

Graybug Vision's initial public offering (IPO) was on 04 September 2020

Is Graybug Vision in the S&P 500?

No, Graybug Vision is not included in the S&P 500 index

Is Graybug Vision in the NASDAQ 100?

No, Graybug Vision is not included in the NASDAQ 100 index

Is Graybug Vision in the Dow Jones?

No, Graybug Vision is not included in the Dow Jones index

When was Graybug Vision's last earnings report?

Graybug Vision's most recent earnings report was on 12 November 2021

When does Graybug Vision report earnings?

The date for Graybug Vision's next earnings report has not been announced yet

Should I buy Graybug Vision stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions